母体嵌合体对无创产前诊断的挑战
本研究在为四种罕见常染色体显性或X连锁疾病(原判为新发致病或可能致病变异)夫妇开发基于微滴数字PCR的排除性无创产前诊断时,于检测验证阶段在70例个性化检测中检出4例(5.7%)母体体细胞嵌合体(3%-9%),导致无创产前诊断因母源等位基因干扰而不可行;每对夫妇均被告知复发风险升高,并根据其意愿选择侵入性产前诊断或密集超声随访;回顾性分析母体测序数据证实了常规分析中被过滤掉的低水平嵌合体。
要点
- 排除性无创产前诊断检测验证阶段可意外检出母体体细胞嵌合体(70例中4例,5.7%;嵌合比例3%-9%)。
- 母体嵌合体因母源等位基因干扰使排除性无创产前诊断不可行,需告知夫妇复发风险升高。
- 检出后根据夫妇意愿选择侵入性产前诊断或密集超声随访。
核心结论
- 这些病例凸显了存在母体嵌合体时排除性无创产前诊断的一个关键局限性。
- 识别母体嵌合体对于准确的复发风险评估和遗传咨询至关重要。
- 敏感检测方法、仔细的检测前评估和透明的沟通对于确保知情的生殖决策至关重要。
研究设计与样本
- 研究为针对四种罕见常染色体显性或X连锁疾病(原判为新发致病或可能致病变异)夫妇开发基于微滴数字PCR的排除性无创产前诊断检测,检测设计用于在母体血浆中检测胎儿特异性变异,并在父母和先证者样本上进行验证。
主要发现
- 在70例个性化无创产前诊断检测中,4例(5.7%)在检测验证期间检出母体体细胞嵌合体(3%-9%),因母源等位基因干扰导致无创产前诊断不可行。
- 每对夫妇均被告知复发风险升高,并根据其偏好选择侵入性产前诊断或密集超声随访。
- 对母体测序数据的回顾性分析证实了常规分析中被过滤掉的低水平嵌合体。
临床怎么用
- 作者认为这些病例凸显了存在母体嵌合体时排除性无创产前诊断的关键局限性,识别母体嵌合体对于准确复发风险评估和遗传咨询至关重要,敏感检测方法、仔细检测前评估和透明沟通对于确保知情生殖决策至关重要。
局限性
- 原文报告了存在母体嵌合体时排除性无创产前诊断的关键局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the incidental detection of maternal somatic mosaicism during the development of exclusion-based non-invasive prenatal diagnosis for monogenic disorders (NIPD-MD) initially indicated for apparently de novo pathogenic or likely pathogenic variants. METHOD: A droplet digital PCR (ddPCR)-based exclusion NIPD_MD assay was developed for four couples, each with a prior pregnancy affected by a rare autosomal dominant or X-linked condition due to a de novo pathogenic or likely pathogenic variant. Assays were designed to detect fetal-specific variants in maternal plasma, with validation performed on parental and proband samples. RESULTS: In four cases, maternal somatic mosaicism (3%-9%) among 70 personalized NIPD_MD (5.7%) was identified during assay validation, rendering NIPD_MD infeasible due to interference from maternal alleles. Each couple was informed of the elevated recurrence risk. Depending on their preferences, invasive prenatal testing or intensive ultrasound follow-up was undertaken. Retrospective analysis of maternal sequencing data confirmed low-level mosaicism that had been filtered out during routine analysis. CONCLUSION: These cases underscore a key limitation of exclusion NIPD_MD when maternal mosaicism is present. Its identification is essential for accurate recurrence risk estimation and genetic counseling. Sensitive detection methods, careful pre-test evaluation, and transparent communication are critical to ensure informed reproductive decision-making.
引用
- Comel M, Lamairia M, Boute O, et al. Maternal Mosaicism Challenges in Non-Invasive Prenatal Diagnosis. Prenat Diagn. 2025. PMID: 40803994. doi:10.1002/pd.6868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。